A study of 22 patients who were diagnosed with cutaneous T-cell lymphoma (CTCL) after failing to respond to TNF-a inhibitors found that 3⁄4 of patients were being treated for what they believed were inflammatory skin conditions (mainly psoriasis and AD). The gene discussed is TNF; the disease is Alzheimer disease.